Form 4 Filing for Morris Gabriel S

This filing details a Form 4 filed by Morris Gabriel S, CFO, President, and Director of Immix Biopharma, Inc. (IMMX). On May 22, 2026, Mr. Morris acquired 500,000 Stock Options (Right to Buy) with a transaction code indicating acquisition. The options have an exercise price of $8.78 and an expiration date of May 22, 2036. These options will vest in 48 equal monthly installments, contingent upon continued service. Following this transaction, Mr. Morris holds 500,000 shares of Common Stock underlying these options. The filing was signed on May 29, 2026.